Challenges in Managing Recurrent Small Bowel Obstruction in a Patient With Concurrent Hepatic Dysfunction and Alcohol Use Disorder: A Multidisciplinary Approach. [PDF]
Sevgi K, Enman L, Lucero F, Aran SN.
europepmc +1 more source
Endocrine-Disrupting Chemicals: A Looming Threat to Current and Future Generations. [PDF]
Cortes-Ramirez SA, Ho SM, Leung YK.
europepmc +1 more source
Management of Yellow Phosphorus-Induced Acute Liver Failure: A Case Report and Review of Literature. [PDF]
R R, Routray M.
europepmc +1 more source
Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury. [PDF]
Halegoua-DeMarzio D +22 more
europepmc +1 more source
Microcystin shapes the Microcystis phycosphere through community filtering and by influencing cross-feeding interactions. [PDF]
Große R +5 more
europepmc +1 more source
Microcystin-LR Drives Early NAFLD Pathogenesis via Hepatic Cholesterol Accumulation: Dysregulation of <i>Ldlr</i> and <i>Abcg1</i> Expression Uncoupled from <i>Srebp2</i>. [PDF]
Kawahara H +10 more
europepmc +1 more source
Related searches:
Detection of the cyanobacterial hepatotoxins microcystins
Toxicology and Applied Pharmacology, 2005Concern regarding the presence of microcystins in drinking water and their possible contamination in food (e.g., salad vegetables, fish, shellfish) has resulted in the need for reliable methods for the detection and accurate quantification of this class of toxins.
Jacqui, McElhiney, Linda A, Lawton
openaire +2 more sources
Although essential for life, iron in excessive amounts may be toxic. The liver is particularly subject to the toxic effects of iron, since it is the major site of iron storage. Several inherited and acquired human disorders may result in hepatic iron overload, the most common of which are genetic hemochromatosis (GH) and transfusional iron overload. GH
openaire +2 more sources
Papaverine Revisited as a Hepatotoxin
New England Journal of Medicine, 1969The proliferation of therapeutic agents during the past quarter-century has been accompanied by an increased frequency of drug-induced hepatic disease.1 , 2 Usually, the ability of an agent to produce hepatic injury is recognized within a few years of its introduction into clinical use.
openaire +2 more sources
Hepatotoxin-induced hypertyrosinemia and its toxicological significance
Archives of Toxicology, 2006A (1)H Nuclear Magnetic Resonance (NMR) spectroscopic investigation of the effects of single doses of four model hepatotoxins on male Sprague-Dawley rats showed that hypertyrosinemia was induced by three of the treatments (ethionine 300 mg/kg, galactosamine hydrochloride 800 mg/kg and isoniazid 400 mg/kg) but not by the fourth (thioacetamide 200 mg/kg).
T Andrew, Clayton +7 more
openaire +2 more sources

